Concepedia

David Powers

DP

25

Publications

1.3K

Citations

22

H-Index

1979

Active since

Affiliations

Amgen (United States)(Current)

New Frontier

David Powers is an author at Amgen (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1979–2019

25

Publications

25

Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro

James M. Samanen, F. E. ALI, Todd T. Romoff et al. · Journal of Medicinal Chemistry · 1991 · 192 citations · Full text

p38 MAP kinase inhibitors: many are made, but few are chosen.

Celia Dominguez, David Powers, Nuria Tamayo · PubMed · 2005 · 166 citations

, , +20

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Kent Miner, Katja Labitzke, Benxian Liu et al. · Frontiers in Pharmacology · 2019 · 132 citations · Full text

Increasing gene expression in yeast by fusion to ubiquitin

David J. Ecker, Jeffrey M. Stadel, Tauseef R. Butt et al. · Journal of Biological Chemistry · 1989 · 94 citations · Full text

Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck:  Synthesis, SAR, and in Vivo Anti-Inflammatory Activity

Erin F. DiMauro, John Newcomb, Joseph J. Nunes et al. · Journal of Medicinal Chemistry · 2006 · 67 citations · Full text

, , +20

Rows per page

1–5 of 25